The “old” and the “new” antibiotics for MDR gram-negative pathogens: for whom, when, and how
The recent expansion of multidrug resistant and pan-drug-resistant pathogens poses
significant challenges in the treatment of healthcare associated infections. An important
advancement, is a handful of recently launched new antibiotics targeting some of the current
most problematic Gram-negative pathogens, namely carbapenem-producing
Enterobacteriaceae (CRE) and carbapenem-resistant P. aeruginosa (CRPA). Less options
are available against carbapenem-resistant Acinetobacter baumannii (CRAB) and strains …
significant challenges in the treatment of healthcare associated infections. An important
advancement, is a handful of recently launched new antibiotics targeting some of the current
most problematic Gram-negative pathogens, namely carbapenem-producing
Enterobacteriaceae (CRE) and carbapenem-resistant P. aeruginosa (CRPA). Less options
are available against carbapenem-resistant Acinetobacter baumannii (CRAB) and strains …
[引用][C] The “Old” and the “New” antibiotics for MDR Gram-negative pathogens: For whom, when, and how. Front Public Health. 2019; 7: 151
I Karaiskos, S Lagou, K Pontikis, V Rapti, G Poulakou - 2019
以上显示的是最相近的搜索结果。 查看全部搜索结果